Fresenius Targets Nostrum's Generic PhosLo GelCaps
By Megan Leonhardt ( January 17, 2012, 2:44 PM EST) -- Fresenius Medical Care Holdings Inc. on Friday lodged a patent infringement suit in Massachusetts federal court in an effort to block Nostrum Laboratories Inc. from marketing a generic version of kidney failure treatment PhosLo GelCaps....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.